IP Library Granted Patent US 8,299,242
Granted Patent B2
US 8,299,242 · App. 12/829,126 · Granted Oct 30, 2012

Synthesis of 2,4-pyrimidinediamines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,299,242
App. No.
12/829,126
Granted
Oct 30, 2012
Kind
B2
Abstract

Disclosed herein are methods for synthesizing 2,4-pyrimidinediamines as well as intermediates used therein.

Claims (16)

1. A process for preparing a compound of formula I:

comprising:

a) contacting an acid solvate of a compound of formula II:

 with an amide under conditions suitable for forming an amide solvate of the compound of formula II; and

b) contacting the amide solvate with an aqueous base comprising sodium ions under conditions suitable for forming the compound of formula I

wherein the carboxylic acid is R 1 COOH wherein R 1 is —H or a C 1 -C 4 alkyl optionally substituted with up to three halo; and

the amide is R 30 CON(R 2 ) 2 where each R 2 is independently —H or C 1 -C 4 alkyl or both R 2 together with the nitrogen to which they are attached form a 4 to 6 membered aliphatic ring, and R 30 is —H or C 1 -C 4 alkyl; or R 30 and one of the R 2 together with the carbon and nitrogen to which they are attached, respectively, combine to form a 4 to 6-membered aliphatic ring and the other R 2 is independently —H or C 1 -C 4 alkyl.

2. The process of claim 1 , wherein the amide is a N,N-dialkylformamide, N,N-dialkylacetamide, N-alkylpyrrolidinone, or N-alkylpiperidone.

3. The process of claim 2 , wherein the amide is the N,N-dialkylformamide; and

the conditions suitable for forming the amide solvate of the compound of formula II comprise a temperature of between about 20° C. and about 70° C.

4. The process of claim 3 , wherein the amide is N,N-dimethylformamide (DMF);

and the conditions suitable for forming the amide solvate comprise re-slurrying of the acid solvate in the DMF at a temperature of about 50° C.

5. The process of claim 1 , wherein the aqueous base in part b) comprises sodium hydroxide and an alcohol, and the conditions suitable for forming the compound of formula I comprise a temperature of between about 40° C. about 80° C. and a pH of about 8 to about 10.5.

6. The process of claim 5 , wherein the aqueous base in step b) comprises sodium hydroxide (NaOH) and isopropyl alcohol (IPA), and the conditions suitable for forming the compound of formula I comprise a temperature of about 80° C. and a pH of about 9.

7. The process according to claim 1 wherein the compound of formula I is in the form of a hydrate.

8. The process according to claim 7 wherein the hydrate is a hexahydrate.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2010
From: FELFER, ULFRIED; GISELBRECHT, KARL-HEINZ; WOLBERG, MICHAEL
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 024685/0784 →